Use of Immune Globulin Intravenous (Human) To Treat Age-Related Macular Degeneration

This study has been completed.

Sponsor:

Information provided by:

Grifols Therapeutics Inc.

ClinicalTrials.gov Identifier:

NCT00220805

First received: September 14, 2005

Last updated: July 23, 2009

Last verified: April 2008

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	May 2005
Estimated Primary Completion Date:	No date given